Leerink Partnrs Issues Negative Outlook for BCYC Earnings
Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) – Investment analysts at Leerink Partnrs decreased their Q1 2025 earnings per share estimates for shares of Bicycle Therapeutics in a research note issued to investors on Tuesday, February 25th. Leerink Partnrs analyst J. Chang now expects that the company will earn ($0.85) per share for the quarter, […]
